Samir Mitragotri

Updated on Oct 05, 2024

Edit

Comment

Residence USA Name Samir Mitragotri		Role Professor

Born May 28, 1971 (age 53) Solapur, India ( 1971-05-28 ) Institutions University of California, Santa BarbaraDuncan and Suzanne Mellichamp Chair in Systems Biology and BioengineeringProfessor, Chemical EngineeringDirector, Center of BioEngineeringScientific Director, Translational Medicine Research LabAffiliated Faculty, Technology Management Program Alma mater B.S., Institute of Chemical Technology, 1992M.S. and Ph.D., Massachusetts Institute of Technology, 1996 Known for Drug Delivery, Biomaterials Education Institute of Chemical Technology, Massachusetts Institute of Technology Fields Chemical Engineering, Biomedical engineering Similar People Robert S Langer, Ali Khademhosseini, Nicholas A Peppas, Tejal A Desai
Doctoral advisor Robert S. Langer

Mmla 2014 pursakar winner samir mitragotri

Samir Mitragotri (born May 28, 1971) is an Indian American Professor at the University of California, Santa Barbara, an inventor, an entrepreneur, and a researcher in the fields of drug delivery and biomaterials. He is currently the Duncan and Suzanne Mellichamp Chair in Systems Biology and Bioengineering and the Founding Director of the UC Santa Barbara Center for BioEngineering. In 2017, Prof. Mitragotri will move to the Harvard University John A. Paulson School of Engineering and Applied Sciences and the Wyss Institute for Biologically Inspired Engineering.

Prof. Mitragotri has made groundbreaking contributions to the field of drug delivery by advancing fundamental understanding of biological barriers and developing new materials and technologies for drug delivery. Many of his technologies have advanced to human clinical studies and products. Prof. Mitragotri has established a fundamental knowledge platform of transport properties of skin. He also developed mathematical models of skin permeation and analytical tools to study biophysics of skin structure-function relationship. He has pioneered a large number of technologies including low-frequency ultrasound, pulsed microjet injector, high throughput skin experimentation, skin penetrating peptides and ionic liquids for transdermal delivery of proteins, peptides and nucleic acids. Prof. Mitragotri has also developed fundamental understanding of trans-epithelial transport in the intestine. He also developed novel technologies, in particular intestinal patches, for oral delivery of proteins such as insulin and calcitonin. Prof. Mitragotri has designed and synthesized unique bio-inspired nanoparticles of novel physical, chemical and biological properties to understand the fundamental principles of body’s immune barrier. He developed novel particles that mimic red blood cells and platelets as well as hybrid systems that make use of synthetic nanoparticles hitchhiking on natural cells for targeted delivery of drugs.

Mitragotri has published over 210 publications in the area of drug delivery and biomaterials, has given close to 500 invited and contributed presentations worldwide, and is an inventor on over 150 patents/applications. His publications are cited with an h-index of 79. Mitragotri is a co-founder of several companies that are developing products based on his inventions for detection and treatment of various human diseases. He received his Ph.D. in Chemical Engineering at MIT and B.S. in Chemical Engineering from the Institute of Chemical Technology. Mitragotri serves on the editorial boards of several journals and currently serves as Editor-in-Chief of Bioengineering and Translational Medicine.